LifeStance Health Group, Inc. (NASDAQ:LFST) Receives Consensus Rating of “Hold” from Analysts

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) have been given a consensus recommendation of “Hold” by the five brokerages that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have given a buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $8.63.

Several analysts recently weighed in on LFST shares. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a research note on Friday, February 28th. Canaccord Genuity Group initiated coverage on LifeStance Health Group in a report on Thursday. They set a “buy” rating and a $8.00 target price on the stock. Finally, The Goldman Sachs Group upgraded LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target on the stock in a research report on Monday, December 16th.

LifeStance Health Group Price Performance

NASDAQ:LFST opened at $6.63 on Thursday. LifeStance Health Group has a one year low of $4.64 and a one year high of $8.61. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market cap of $2.55 billion, a PE ratio of -25.50 and a beta of 1.27. The firm’s 50 day simple moving average is $7.52 and its 200 day simple moving average is $7.34.

Insider Activity at LifeStance Health Group

In other news, insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the transaction, the insider now directly owns 339,810 shares of the company’s stock, valued at approximately $2,344,689. This trade represents a 5.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 6.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On LifeStance Health Group

Several large investors have recently added to or reduced their stakes in LFST. Jennison Associates LLC boosted its holdings in shares of LifeStance Health Group by 278.4% during the 4th quarter. Jennison Associates LLC now owns 8,086,380 shares of the company’s stock worth $59,597,000 after buying an additional 5,949,438 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in LifeStance Health Group by 87.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company’s stock worth $25,977,000 after acquiring an additional 1,643,390 shares in the last quarter. Vanguard Group Inc. grew its holdings in LifeStance Health Group by 7.9% in the fourth quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company’s stock worth $78,781,000 after purchasing an additional 784,818 shares during the period. Geode Capital Management LLC increased its stake in LifeStance Health Group by 26.8% in the third quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company’s stock valued at $24,170,000 after purchasing an additional 729,794 shares in the last quarter. Finally, Wellington Management Group LLP raised its holdings in shares of LifeStance Health Group by 15.2% during the third quarter. Wellington Management Group LLP now owns 4,830,441 shares of the company’s stock valued at $33,813,000 after purchasing an additional 638,385 shares during the period. Institutional investors and hedge funds own 85.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.